Novel mechanisms of salt-sensitive hypertension

被引:13
|
作者
Vogt, Liffert [1 ]
Marques, Francine Z. [2 ,3 ]
Fujita, Toshiro [4 ]
Hoorn, Ewout J. [5 ]
Danser, A. H. Jan [6 ,7 ]
机构
[1] Univ Amsterdam, Amsterdam Univ, Amsterdam Cardiovasc Sci, Dept Internal Med,Sect Nephrol,Med Ctr, Amsterdam, Netherlands
[2] Monash Univ, Sch Biol Sci, Hypertens Res Lab, Melbourne, Vic, Australia
[3] Baker Heart & Diabet Inst, Heart Failure Res Grp, Melbourne, Vic, Australia
[4] Univ Tokyo, Res Ctr Adv Sci & Technol RCAST, Tokyo, Japan
[5] Univ Med Ctr, Erasmus MC, Dept Internal Med, Div Nephrol & Transplantat, Rotterdam, Netherlands
[6] Univ Med Ctr, Erasmus MC, Dept Internal Med, Div Vasc Med & Pharmacol, Rotterdam, Netherlands
[7] Erasmus MC, Dept Internal Med, Room Ee-1418B,Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands
基金
英国医学研究理事会;
关键词
aldosterone synthase inhibitors; epigenetics; gut-kidney axis; inflammation; microbiome; sodium-glucose cotransporter 2; BLOOD-PRESSURE; MINERALOCORTICOID RECEPTOR; GUT MICROBIOTA; KIDNEY-DISEASE; SODIUM; FINERENONE; PREVENT; TARGET; INJURY;
D O I
10.1016/j.kint.2023.06.035
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A high dietary sodium-consumption level is considered the most important lifestyle factor that can be modified to help prevent an increase in blood pressure and the development of hypertension. Despite numerous studies over the past decades, the pathophysiology explaining why some people show a salt-sensitive blood pressure response and others do not is incompletely understood. Here, a brief overview of the latest mechanistic insights is provided, focusing on the mononuclear phagocytic system and inflammation, the gut-kidney axis, and epigenetics. The article also discusses the effects of 3 types of novel drugs on salt-sensitive hypertension-sodium-glucose cotransporter 2 inhibitors, nonsteroidal mineralocorticoid receptor antagonists, and aldosterone synthase inhibitors. The conclusion is that besides kidney-centered mechanisms, vasoconstrictor mechanisms are also relevant for both the understanding and treatment of this blood pressure phenotype.
引用
收藏
页码:690 / 697
页数:8
相关论文
共 50 条
  • [21] Lysine and salt-sensitive hypertension
    Dissanayake, Lashodya V.
    Palygin, Oleg
    Staruschenko, Alexander
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2024, 33 (04): : 441 - 446
  • [22] Genetics of Salt-Sensitive Hypertension
    Sanada, Hironobu
    Jones, John E.
    Jose, Pedro A.
    CURRENT HYPERTENSION REPORTS, 2011, 13 (01) : 55 - 66
  • [23] Genetics of Salt-Sensitive Hypertension
    Hironobu Sanada
    John E. Jones
    Pedro A. Jose
    Current Hypertension Reports, 2011, 13 : 55 - 66
  • [24] Salbutamol and salt-sensitive hypertension
    Bailey, Matthew A.
    KIDNEY INTERNATIONAL, 2021, 100 (02) : 272 - 275
  • [25] The brain and salt-sensitive hypertension
    Leenen, FHH
    Ruzicka, M
    Huang, BS
    CURRENT HYPERTENSION REPORTS, 2002, 4 (02) : 129 - 135
  • [26] Salt-Sensitive Hypertension and the Kidney
    Nishimoto, Mitsuhiro
    Griffin, Karen A.
    Wynne, Brandi M.
    Fujita, Toshiro
    HYPERTENSION, 2024, 81 (06) : 1206 - 1217
  • [27] Possible mechanisms of salt-induced hypertension in Dahl salt-sensitive rats
    Bayorh, MA
    Ogbolu, EC
    Williams, E
    Thierry-Palmer, M
    Sanford, G
    Emmett, N
    Harris-Hooker, S
    Socci, RR
    Chu, TC
    Chenault, VM
    PHYSIOLOGY & BEHAVIOR, 1998, 65 (03) : 563 - 568
  • [28] A Novel Role of Fumarate Metabolism in Dahl Salt-Sensitive Hypertension
    Tian, Zhongmin
    Liu, Yong
    Usa, Kristie
    Mladinov, Domagoj
    Fang, Yi
    Ding, Xiaoqiang
    Greene, Andrew S.
    Cowley, Allen W., Jr.
    Liang, Mingyu
    HYPERTENSION, 2009, 54 (04) : E63 - E64
  • [29] The Kidney and Hypertension: Pathogenesis of Salt-Sensitive Hypertension
    Shimosawa, Tatsuo
    Mu, Shengyu
    Shibata, Shigeru
    Fujita, Toshiro
    CURRENT HYPERTENSION REPORTS, 2012, 14 (05) : 468 - 472
  • [30] The Kidney and Hypertension: Pathogenesis of Salt-Sensitive Hypertension
    Tatsuo Shimosawa
    Shengyu Mu
    Shigeru Shibata
    Toshiro Fujita
    Current Hypertension Reports, 2012, 14 : 468 - 472